Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial

Journal of Clinical Oncology

Volumn 29, Issue 20, 2011, Pages 2773-2780

  Aschele, Carlo ^a   Cionini, Luca ^b   Lonardi, Sara ^c   Pinto, Carmine ^d   Cordio, Stefano ^e   Rosati, Gerardo ^f   Artale, Salvatore ^g   Tagliagambe, Angiolo ^h   Ambrosini, Giovanni ⁱ   Rosetti, Paola ^j   Bonetti, Andrea ^k   Negru, Maria Emanuela ^l   Tronconi, Maria Chiara ^m   Luppi, Gabriele ⁿ   Silvano, Giovanni ^o   Corsi, Domenico Cristiano ^p   Bochicchio, Anna Maria ^q   Chiaulon, Germana ^r   Gallo, Maurizio ^a   Boni, Luca ^s  

^a UNIVERSITY OF GENOA   (Italy)

^b Centro Oncologico Fiorentino   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e GARIBALDI HOSPITAL   (Italy)

^f SAN CARLO HOSPITAL   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h Azienda Sanitaria Locale 1   (Italy)

ⁱ SANTA CHIARA HOSPITAL   (Italy)

^j DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^k Ospedale Mater Salutis   (Italy)

^l Universitaria Maggiore Della Carita   (Italy)

^m HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

ⁿ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^o Ambulatorio di Dermatologia   (Italy)

^p Ospedale San Giovanni Calibita Fatebenefratelli   (Italy)

^q Ospedale Oncologico Regionale   (Italy)

^r SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^s ISTITUTO TOSCANO TUMORI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; DIARRHEA; DYSURIA; FEMALE; FEVER; HUMAN; INTRAABDOMINAL METASTASIS; LAPAROTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; SENSORY DYSFUNCTION; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE FRACTIONATION; DRUG TOXICITY; FEMALE; FLUOROURACIL; HUMANS; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79960242791     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.34.4911     Document Type: Article

References (33)

1. Gérard JP, Conroy T, Bonnetain F, et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625, 2006 (Pubitemid 46630960)
2. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006 (Pubitemid 44394918)
3. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
4. Bosset JF, Calais G, Mineur L, et al: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921. J Clin Oncol 23: 5620-5627, 2005
5. Aschele C, Lonardi S: Multidisciplinary treatment of rectal cancer: Medical oncology. Ann Oncol 18:1908-1915, 2007
6. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
7. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000 (Pubitemid 30644117)
8. Blackstock AW, Hess S, Chaney S, et al: Oxaliplatin: In vitro evidence of its radiation sensitizing activity - Pre-clinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys 45:3s, 1999 (suppl; abstr 202)
9. Aschele C, Friso ML, Pucciarelli S, et al: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16: 1140-1146, 2005 (Pubitemid 41418317)
10. Arbuck SG, Ivy SP, Setser A, et al: The revised Common Toxicity Criteria: Version 2.0. Cancer Therapy Evaluation Program. http://ctep.info.nih.gov
11. Trotti A, Byhardt R, Stetz J, et al: Common toxicity criteria: Version 2.0 - An improved reference for grading the acute effects of cancer treatment. Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13-47, 2000 (Pubitemid 30179675)
12. Quirke P, Williams GT: Minimum Dataset for Colorectal Cancer Histopathology Reports. London, United Kingdom, Royal College of Pathologists, 1998
13. Sobin LH, Wittekind CH (eds): International Union Against Cancer (UICC) TNM classification of malignant tumours, 5th ed. New York, NY, John Wiley & Sons, 1997
14. Wittekind C, Compton C, Quirke P, et al: A uniform residual tumor (R) classification: Integration of the R classification and the circumferential margin status. Cancer 115:3483-3488, 2009
15. Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19-23, 1997 (Pubitemid 27138353)
16. Freyer G, Bossard N, Romestaing P, et al: Addition of oxaliplatin to continuous fluorouracil l-folinic acid and concomitant radiotherapy in rectal cancer: The Lyon R97-03 phase I trial. J Clin Oncol 19:2433-2438, 2001 (Pubitemid 32391214)
17. Carraro S, Roca EL, Cartelli C, et al: Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and FU in T3-T4 unresectable rectal cancer: A phase II IATTGI study. Int J Radiat Oncol Biol Phys 54:397-402, 2002 (Pubitemid 35286803)
18. Rödel C, Grabenbauer GG, Papadopoulos T, et al: Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104, 2003 (Pubitemid 46613485)
19. Cividalli A, Ceciarelli F, Livdi E, et al: Radio-sensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule. Int J Radiat Oncol Biol Phys 52:1092-1098, 2002 (Pubitemid 34219031)
20. Ryan DP, Niedzwiecki D, Hollis D, et al: Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 24:2557-2562, 2006 (Pubitemid 46630634)
21. Gérard JP, Azria D, Gourgou-Bourgade S, et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644, 2010
22. Mohiuddin M, Winter K, Mitchell E, et al: Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012. J Clin Oncol 24:650-655, 2006 (Pubitemid 46630429)
23. Gerard JP, Chapet O, Nemoz C, et al: Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 22:2404-2409, 2004 (Pubitemid 41115397)
24. National Surgical Adjuvant Breast and Bowel Project (NSABP): Clinical trials overview: Protocol R-04. http://www.nsabp.pitt.edu/R-04.asp
25. Italian Medicines Agency (Agenzia Italiana del Farmaco; AIFA): List of drugs with consolidated use in the treatment of solid tumors but for indications not included in the provision of marketing authorisation [in Italian]. http://www.agenziafarmaco.it/sites/default/files/all-oncologia-adulti-230609.pdf
26. Czito BG, Bendell JC, Willett CG, et al: Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys 68:472-478, 2007 (Pubitemid 46694189)
27. Rödel C, Arnold D, Hipp M, et al: Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys 70:1081-1086, 2008 (Pubitemid 351296110)
28. Chau I, Brown G, Cunningham D, et al: Neo-adjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging: Defined poor-risk rectal cancer. J Clin Oncol 24:668-674, 2006 (Pubitemid 46630432)
29. Fernández-Martos C, Pericay C, Aparicio J, et al: Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J Clin Oncol 28:859-865, 2010
30. De Ridder M, Tournel K, Van Nieuwenhove Y, et al: Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 70:728-734, 2008 (Pubitemid 351199707)
31. Tournel K, De Ridder M, Engels B, et al: Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 71:934-939, 2008 (Pubitemid 351749525)
32. Engels B, De Ridder M, Tournel K, et al: Preoperative helical tomotherapy and Megavolt Computed Tomography for rectal cancer: Impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 74:1476-1480, 2009
33. Methy N, Bedenne L, Conroy T, et al: Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: Statistical evaluation based on the FFCD 9203 trial. Ann Oncol 21:518-524, 2010